Summary
- Main use
- Amino acid supplementation in severe hepatic impairment; treatment of hepatic coma
- Who receives it
- Adults
- Adult administration
- ○ Adults: Generally, administer by intravenous drip up to a maximum total amino acid dose of 1.5 g per kg of body weight per day (equivalent to 1300 mL per day for a body weight of 70 kg). ○ Infusion rate: Maximum of 1.25 mL per kg of body weight over 60 minutes.
Ingredients
- L-Isoleucine1.04g / 100mL
- L-Leucine1.309g / 100mL
- L-Lysine Acetate0.971g / 100mL
- L-Methionine0.11g / 100mL
- N-Acetyl-L-Cysteine0.07g / 100mL
- L-Phenylalanine0.088g / 100mL
- L-Threonine0.44g / 100mL
- L-Tryptophan0.07g / 100mL
- L-Valine1.008g / 100mL
- L-Arginine1.072g / 100mL
- L-Histidine0.28g / 100mL
- Glycine0.582g / 100mL
- L-Alanine0.464g / 100mL
- L-Proline0.573g / 100mL
- L-Serine0.224g / 100mL
- Manufacturer
- Hanol Biopharma Co., Ltd.
Efficacy & effects
Amino acid supplementation in severe hepatic impairment; treatment of hepatic coma
- Brain function damage
- severe liver dysfunction
- hepatic encephalopathy
View approved original textHide original text
This medication can be used in cases of severe liver dysfunction, regardless of whether there is accompanying brain function damage due to liver failure. It is also effective in treating hepatic encephalopathy. In such cases, the administration of amino acids non-orally helps support liver function and protect brain function. Therefore, this drug is used to improve the condition in cases of liver failure or hepatic encephalopathy.
How it is given
Adult administration
○ Adults: Generally, administer by intravenous drip up to a maximum total amino acid dose of 1.5 g per kg of body weight per day (equivalent to 1300 mL per day for a body weight of 70 kg). ○ Infusion rate: Maximum of 1.25 mL per kg of body weight over 60 minutes.
Precautions
This drug must be used strictly according to a doctor's instructions. It should not be administered to patients with poor kidney function or high blood nitrogen levels, patients with liver dysfunction, and those with issues in amino acid metabolism. Avoid use in patients with weak heart function, pulmonary edema, oliguria, acidosis, and those receiving excessive fluids. Do not administer to patients with a history of myocardial infarction, hyponatremia, shock, or hypoxia. Use with caution in patients with edema due to sodium retention, kidney disease, lung disease, severe heart disease history, or diabetes. Rarely, hypersensitivity reactions such as skin rash may occur when using this drug. If such symptoms appear, administration should be stopped immediately. Gastrointestinal symptoms like nausea and vomiting, as well as cardiovascular symptoms such as chest discomfort, rapid pulse, and elevated blood pressure may also occur. Administering a large volume suddenly may cause acidosis; care should be taken to avoid this. Serious adverse reactions such as chills, fever, headache, difficulty breathing, and shock have also been reported, though rarely. Various metabolic complications can occur, including metabolic acidosis, hypophosphatemia, and hyperglycemia, so they should be closely monitored. In patients with renal failure, blood BUN levels may rise when using this drug. Regular checks of blood glucose, electrolytes, fluids, acid-base balance, and liver function should be conducted during administration. This drug carries a risk of microbial contamination when mixed with other medications; therefore, it should only be mixed with products whose safety has been confirmed. Women who are pregnant or breastfeeding should only use this drug under a doctor's judgment, as its safety is not certain. In children, liver function may be immature, so concentrations should be kept low and blood ammonia levels should be checked frequently. In the elderly, body function may decline, so administration speed should be slow, and the dosage should be adjusted. Attention should be paid to electrolyte balance during administration, and it should not be infused quickly. The solution should be warmed to body temperature, and aseptic conditions for preparation and management should be maintained to reduce infection risks. Do not use if the solution is cloudy or discolored before administration; once prepared, it should be used as soon as possible and not stored in the refrigerator for more than 24 hours after preparation.
Side effects
- Rash
- nausea
- vomiting
- chest discomfort
- palpitations
- rapid heartbeat
- increased blood pressure
- acidosis
- chills
- fever
Show 21 moreCollapse
- headache
- difficulty breathing
- respiratory arrest
- shock
- bronchospasm
- ureteral spasm
- metabolic acidosis
- hypophosphatemia
- alkalosis
- hyperglycemia
- diabetes
- osmotic diuresis
- dehydration
- reactive hypoglycemia
- elevated liver enzymes
- vitamin deficiency
- vitamin excess
- electrolyte imbalance
- pediatric hyperammonemia
- elevated BUN
- changes in serum ammonia levels
Not everyone experiences these, and they can vary from person to person.
Storage
This medication should be stored in a sealed container that prevents air or moisture from entering, away from direct sunlight, and at room temperature. This storage method helps maintain the medication's effectiveness and prevent deterioration.
Appearance and packaging
Appearance
An injection solution in a colorless and transparent vial.
Package unit
200 mL/bottle, 250 mL/bottle
Questions about this medicine
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.